Monday, October 30, 2017

The Sound of Silence (Musings on Health Canada's Expert Panel on Immune Globulin Product Supply)

Updated: 31 Oct. 2017  (Fixed typos) 
For October I've written a two-fer, one blog in two parts. This second blog focuses on Canada's blood regulator (Health Canada) setting up an Expert Panel on Immune Globulin Product Supply & Related Impacts. Musings will be on why the panel was set up, why now, and the impact of who its members are.

Part Two was stimulated by something I came across purely by serendipity (because Health Canada does not widely advertise to the public matters related to the blood system), namely, an update to Health Canada's Expert Panel on Immune Globulin Product Supply & Related Impacts. Discovering the new members of HC's expert panel sealed the two-fer deal. This too was a blog I had to write.

Why read the blog? To me, it helps if everyone involved in transfusion medicine in local, regional, national, global communities is aware of events occurring at a high level with 'biggies' (so-called 'thought-leaders') involved and driving the process and outcomes. That way, the 'hoi polloi', we trench workers, aren't blind-sided by decisions that seem to come out of nowhere from above.

Plus it's not so much that HC's panel is an example of GIGO (garbage in, garbage out):
  • Computer science acronym in which bad input will result in bad output. Because computers use strict logic, invalid input ('garbage') may produce unrecognizable output ('garbage')
It's more that results can be determined by the folks deciding, because even the most well intentioned come with a ton of baggage (experience, biases, and hard-wired beliefs) that influence their views.

Consider for a moment if a US Supreme Court decision was to be made solely by Antonin Scalia vs Ruth Bader Ginsberg, both respected, honorable Justices of integrity. (Google them, if needed)

The blog's title derives from a 1964 Simon and Garfunkel song I've used several times before.

HEALTH CANADA'S EXPERT PANEL: WHAT WE  KNOW 
Or more likely, what we don't know.

Let's discuss why the  Expert Panel on Immune Globulin Product Supply and Related Impacts in Canada was set up, why now, and the impact of who its members are.

WHY
Why was the expert panel set up? The stated aim:
The Expert Panel...will objectively assess the security and sustainability of Canada's immune globulin product supply.

There's that word again, sustainability. Also note the use of 'objectively', perhaps meaning the current catch-phrase of all health-related decisions, evidence-based. Interesting that HC used 'objectively' as if they needed to emphasize that. Who would ever think otherwise, that HC would assess subjectively? [She said, ROTFL]

WHY NOW
Who knows. My guess is that the USA's focus on a sustainable blood system played a role. Perhaps this motivated CBS CEO Graham Sher to ask provinces for $100 million over six years to
make CBS more self-sufficient in collecting plasma? (Further Reading) And less reliant on USA, more important than ever with unpredictable Trump as President?

Or maybe all the protests against paid plasma clinics motivated Health Canada to end the discussion once and for all? Remember in 2013 that they held a round table on paid plasma that was a farce (Further Reading):
  • Day tripper (Musings on HC's instructions to the jury on paid plasma)
PANEL MEMBERS
We now know all four of HC's expert panel members: a Canadian Chair and Deputy Chair, and two 'advisors' both working in the USA. Not that Health Canada advertised them. Fact is, I came across the update by chance. See Further Reading for their details and responses to competing interest questions.

First, the only panel member I've met F2F and talked to is Deputy Chair, Francine Décary, an award-winning transfusion medicine leader who I respect unconditionally. I know the Chair Penny Ballem by reputation only, an experienced physician-administrator. The two advisers are accomplished professionals, in many ways both 'forces of nature'. There is no reason to doubt their integrity.

Yet my skeptical meter is on high alert. Why you may ask? Reasons include HC's prior pro-plasma bias and its four expert panel members. See if you can discern my unease.

1. Chair, Penny Ballem,MD, FRCP, FCAHS 
Deputy Med Director CRC BTS, BC Deputy Minister of Health, Vancouver City manager, and several academic appointments.

Brilliant physician turned 'suit', at which she also excels. Civic and provincial government appointments involved finding ways to cut costs and still provide high level of service.

2. Deputy Chair, Francine Décary,MD, PhD, MBA
Much respected former CEO of Héma-Québec, epitome of person you'd love to have a beer with. Many honours including Order of Canada, was President of ISBT  and Chair of the Foundation for America's Blood Centers.

Dr. Décary is long-time blood system administrator - person responsible for running a business or organization - operating at the highest level in Canada, USA, and globally.

3. Adviser Patrick Roberts, PhD 
Roberts has been involved with the pharmaceutical industry that relies on paid plasma for years and his consulting firm specializes providing information on the plasma derivatives industry.

He was Bayer's (now Grifols) Marketing Research Manager of Plasma Products Division.

Also, he owns individual stocks in plasma companies: CSL Behring, Grifols, and Shire.

He's the President of Marketing Research Bureau (MRB), a supplier of information Big Pharma and more, including Canada's blood supplier, CBS. MRB is an associate member of the Plasma Protein Therapeutics Association (PPTA).

For reference, PPTA represents the private sector, a part of Big Pharma whose business involves collecting, manufacturing, and selling blood-derived plasma products.

From CBC 2013 news item, Paying for blood plasma raises new questions (Further Reading)
"Analyst Patrick Roberts has predicted that the industry will be able to meet future demand, even if a new market develops for IVIG, in treating Alzheimer's, a potential use that is still in clinical trials.  And now, with recent news that the largest placebo controlled clinical trial has been halted because IVIG did not show a statistically significant improvement in functional ability or a reduction in cognitive decline compared to placebo, this anticipated surge in demand for human plasma might never materialize."
Roberts' message: There's no imminent shortage of IVIG. Have conditions dramatically changed in past 4 years?

4, Merlyn Sayers, MBBCh, PhD
Dr. Sayers is President and CEO of Carter BloodCare in Dallas/Fort Worth, previously the Medical Director at the Puget Sound Blood Center in Seattle and was President of America's Blood Centers. Another experienced, respected physician who is a long-time administrator at the highest levels of USA's blood system.

BOTTOM LINE
All of Health Canada's panel members are impressive, accomplished individuals. No doubt HC chose Canadians Drs. Ballem and Décary with a view to shutting down criticism of the panel's conclusions.

Interesting that 3/4 panel members are long-time blood system administrators and one is a consultant who earns a living from the plasma-derivative industry. No doubt HC thinks they can OBJECTIVELY assess the security and sustainability of Canada's immune globulin product supply. I'm not so sure.

FOR FUN
I chose Simon and Garfunkel's song because it seems to me that Health Canada is too often silent on providing Canadians with access to major events involving the blood system. No press releases about updates, no tweets, no nothing. Plus HC has a history of skewing the playing field to get the results they want (Further Reading): Day tripper (Musings on HC's instructions to the jury on paid plasma)
As always comments are most appreciated.

FURTHER READING
Health Canada: Expert Panel on Immune Globulin Product Supply & Related Impacts

Industry advisors to Health Canada's expert panel
MRB: CEO Patrick Robert

Biographies of HC's 4 Panel members
  • Includes 'Questions asked to assess affiliations and interests' and replies.
CBC (25 April, 2013): Paying for blood plasma raises new questions

Canadian Blood Services calls for provincial funding for plasma clinics (26 Jan. 2017)

Day tripper (Musings on HC's instructions to the jury on paid plasma) (12 July 2013)

Take a chance on me (Musings on USA's unsustainable blood system)

Updated: 30 Oct. 2017 (Fixed typos)
For October I've written a two-fer, one blog in two parts. The first part was stimulated by three related items in TraQ's Oct. newsletter (Further Reading):
  • Klein HG, Hrouda JC, Epstein JS. Crisis in the sustainability of the U.S. blood system. N Engl J Med 2017 Oct 12; 377:1485-8.
  • Building a more sustainable U.S. blood system. (Rand Corporation, Research Briefs, Nov. 2016)
  •  Mulcahy AW, Kapinos KA, Briscombe B, et al. Toward a sustainable blood supply in the United States: an analysis. Rand Corporation, 21 Nov. 2016.
PART ONE: This first blog is on USA's non-sustainable blood system. In a way the two blogs Oct. are related. Both involve protecting the SUPPLY of life-saving blood components and products and managing threats to that supply.

EXECUTIVE VERSION: This first blog will discuss sustainability issues in the US blood system. Quite a wake-up call that the American private, market-based blood system is failing.

Why read the blog? To me, it helps if everyone involved in transfusion medicine is aware of the big picture nationally and globally because it helps us interpret background noise that may otherwise fly under the radar.

Moreover, many health professionals outside the USA may not be 'into' the economic conditions that a private blood system, or private healthcare for that matter, operate in.

Allow me two anecdotes. Medical Laboratory Science graduates who went to work in the US in the 1990s told interesting tales of some of the differences between Canada and the US. For example, how each new transfusion service work-up on a patient with difficult red cell antibodies required careful documentation of codes (time-consuming major distractor) in order to charge Medicare / Medicaid properly or to add to the patient's increasing hospital bill.

Or how one grad worked in a Las Vegas mega-lab where technologists were more like factory workers on an assembly line and didn't need to worry about quality control because that was someone else's job. No doubt the huge private lab had wrung every efficiency out of the system in order to decrease costs and compete for business.

The blog's title derives from 1978 ditty by Sweden's ABBA, which I've used once before.

USA BLOOD SYSTEM 
Regarding the USA situation, I recommend viewers read the three fascinating items in Further Reading. The 12 Oct. 2017 'Sounding Board' piece by Klein, Hrouda, and Epstein in New England Journal of Medicine clearly derives from Rand Corporation Research done in Nov. 2016.

What follows are my take-aways about the U.S. blood system. Although I follow events there closely, my grasp of the intricacies of the business side of things is limited. Bear with me as I describe what I see as the 'big pic' of the U.S. system.

Many developed nations have a single, government-funded blood supplier, e.g., Australia, Canada, France, Ireland, New Zealand, UK, and more. The USA opted for a private system composed of non-governmental organizations (NGOs) that sell blood on the open market to hospital clients. The U.S. even has blood brokers who buy from the blood centers who collect and manufacture blood components and sell to hospitals who need components to treat patients.

In the USA's free enterprise blood system, markets rule. The price of blood components and products depend on supply and demand. Suppliers (blood centers) compete for hospital customers based on pricing and service just as for-profit businesses do.

The pressure is on blood centers to produce products more efficiently and reduce the price, or improve a key required quality, so that hospitals will pay more to get it.

Under such a system, assuming no new major injection of funds, businesses, including non-profit blood suppliers, will fail once expenses exceed revenues, and cash reserves and sellable assets are depleted.

THREATS TO SUSTAINABILITY
The following is my take on the NEJM article and related Rand search.

The U.S. free market in blood struggles for several reasons. These include decreased demand for blood components because of
  • Patient blood management programs that reduce the need for transfusion and decrease healthcare costs, while ensuring that blood is available for patients who need transfusion;
  • Less invasive surgical procedures;
  • Development of drugs that reduce surgical blood loss and decrease the need for transfusion.
In business terms, demand for blood center products decreased. Data point: Blood transfusion decreased ~25% from 2008-2017 and may decrease by 40% by 2020. Accordingly, supplier (blood center) revenue decreased and their cost/unit increased.

The result has been that the client/consumer blood system (hospitals) have increased consolidation to decrease their costs. And blood suppliers now must deal with more large institutions with increased bargaining power, further driving down blood center revenues.

Another reality: Apparently U.S. blood collectors are reluctant to introduce new technologies that make the blood supply and transfusion safer because hospitals won't pay for them unless they are government-mandated, e.g., Zika virus and Babesiosis screening, red-cell genotyping.

Of course, today what determines introducing new blood donor screening tests is risk-based decision making, one factor of which includes economic realities. Decision makers look at factors such as
  • Condition prevalence;
  • How serious the condition/disease to be prevented is;
  • Cost of preventing one case.
Bottom line
Most of America's Blood Centers and the American Red Cross  operate at a loss, provide blood components below cost. The American blood system has become unsustainable.

What to do? 
Rand Corporation proposed three alternatives. Let
1. U.S. blood system continue to function as it has;
2. Government play a more active role;
3. Government assume complete responsibility.

Of course, predictably, they opted for #2 in which the U.S. blood system remains privatized but with some additional government intervention. Translation: The government funds and takes care of safety issues for which a good business case cannot be made by the private sector. Perhaps a form of corporate welfare in a good cause?

MY TAKE-AWAY CONCLUSIONS
As the NEJM authors state (no-brainer, obvious to all)
  • Adhering to supply and demand ignores the importance of safe, available blood because blood is more than just another consumer good.
I dig that USA will never opt for a government-funded blood system as many developed nations have. The transition would be too against the 'land of free enterprise' and too messy a transmogrification.

On one level it seems that USA wants to have its cake and eat it too. I'm reminded of private, for-profit healthcare clinics in Canada that the rich can access. They tend to 'cherry-pick' the healthiest patients, who are the easiest and cheapest to treat AND send those who are very sick and unprofitable to treat back into the government-funded public system.

Also seems similar to some businesses that carp about government intervention and regulations, even descend to diss folks on welfare, resent increases in the minimum wage because it affects their bottom line, yet are the first in line when their business is in trouble asking for a government bailout. But perhaps that's too harsh.

FREEDOM TO FAIL
To be philosophical for a moment, a private, free enterprise system based on markets, competition, supply and demand is messy and has proven to be the economic equivalent of democracy, the worst form of government, except for all the others. The quote is attributed to Winston Churchill but it's not his.

As an aside, an original Churchill quote, one that breaks me up:
  • 'The best argument against democracy is a five-minute conversation with the average voter.'
Like all market-based businesses, a private blood system has many freedoms and one is the freedom to fail. To succeed and survive, businesses, including NGOs, must continually eliminate waste, increase efficiency, and offer competitive prices for goods and services.

Even government-funded national blood suppliers like CBS constantly strive to decrease costs. Examples include the
  • Introduction of less well paid 'donor care associates';
  • Consolidation of donor testing and component manufacturing to a few regional centres;
  • Closing a plasma collection clinic because it was cheaper to out-source to the USA.
I wish the US blood system well as it struggle through its cognitive dissonance with upholding a private, market-based free enterprise blood system and realizing that government help in the form of funding is essential for the now dysfunctional system to survive. The market worked as it should for decades, then created a huge Oops!

FOR FUN
I chose this ABBA song as a message to the USA to take a chance on a government-based blood system. Guess I think the only causes worth fighting are the hopeless ones.

That's something U.S. will never do, just as they will never adopt universal healthcare system like Canada's even though it's proven to provide better outcomes at much less cost. They made their bed and are doomed to lie in it.
As always comments are most welcome.

FURTHER READING

Klein HG, Hrouda JC, Epstein JS. Crisis in the sustainability of the U.S. blood system. N Engl J Med 2017 Oct 12; 377:1485-8.

Building a more sustainable U.S. blood system (Rand Corporation, Research Briefs, Nov. 2016)

Mulcahy AW, Kapinos KA, Briscombe B, et al. Toward a sustainable blood supply in the United States: an analysis. Rand Corporation, 21 Nov. 2016.

Wednesday, September 27, 2017

While my guitar gently weeps (Musings on recent transfusion-related news)

September's blog will feature four news items in recent TraQ newsletters, items that are a tad different but worthy of featuring, nonetheless. For links to all featured news items see Further Reading.

EXECUTIVE VERSION: There's no need for one because this blog is just a few comments on a series of 'odds and sods' news items that I find interesting. I hope you do too.

The blog's title derives from a 1968 Beatles ditty by George Harrison I used once before in a 2012 blog.

ITEM #1
Why Canada needs USA sperm [and plasma] (13 Sept. 2017)

The article is by Peter Jaworski, who co-authored, 'Markets Without Limits', the primary thesis of which is, "Anything you may permissibly do for free, you may permissibly do for money."

Peter is a Canadian who teaches 'business ethics' (an oxymoron? - Just joking!) at Georgetown University in the USA and is associated with right wing organizations such as the Canadian Constitution Foundation.

He's getting his views that we should allow selling plasma, sperm, kidneys, indeed any body organ, published in many newspapers and journals. Same ideas, rehashed again and again. That's a well known marketing strategy for today's authors if they want to be successful. And it works because newspapers especially are desperate for free articles.

But in the latest oped to promote his book he (a 'business ethicist') doesn't mention - not one word - about the disgusting history of selling sperm in Canada. Facts (Further Reading), which include:
  • Donor lied about medical history, affecting 26 families;
  • Donors not fully screened for HIV and other infectious diseases;
  • Shortage of Canadian sperm is not that men are unwilling to donate without pay. It's about government health and safety regulations to protect people who use donated sperm and the children they conceive.
ITEM #2
The donor who saved over 2 million children (25 Aug. 2017)

80-year-old Australian James Harrison donated plasma with potent anti-D for ~60 yrs. He recently made his 1157th donation. Until 2015, every batch of anti-D [Rh immune globulin] made in Australia contained his antibodies.

If Mr. Harrison lived in the USA he could have opted to earn significant money from his plasma. Who knows how much if he wisely invested it, since he's unlike most US paid plasma donors, who are need the money and are willing participants (victims) in their own exploitation.

But the Australian chose to donate voluntarily for free. To revise a phase from US politics, 'I'm with him.'

ITEM #3
CSL (Australia): Bullying, sex toys and how CSL got rid of a complaining employee (6 Sept. 2017)

This is a fascinating case in which the employee being bullied was male and his boss was female. To get rid of him, CSL (world leader in the plasma protein biotherapeutics industry) started a campaign to find anything they could use against him, even to the point of discovering he sold sex toys on e-Bay. He was fired.

Australia's Fair Work Commission found that he was unfairly dismissed. His female boss apparently remains at the company.

ITEM #4
Case of a transfusion medicine physician, who with her then spouse, bought 4,000 shares of Immucor in 1982 for $11,000 (7 June 2017)

This real case focuses on the doctor's tax woes in the USA after her share became $1,717,038 in 2011. The Court found the doctor's tax issues were not due to her errors but rather the person who prepared her taxes.

Interesting 'What if': Would the transfusion doc, when she was publishing in medical journals decades ago, have mentioned her Immucor shares? In the 1980s did medical journals have conflict of interest or competing interest requirements?

For interest, the physician in question is now a septuagenarian but still active.

FOR FUN
I chose the song based on the first and third news items. In the first a 'business ethicist' promotes selling body tissues and organs without thought of where that will lead us. Especially how it will lead to the wealthy even more exploiting the poor people in this world.

And result in tissue/organ brokers getting rich off the misery of the poor and disadvantaged. Just as paid plasma companies gain incredible wealth from the needy selling their plasma.

All for the sake of a buck. But conveniently camouflaged under the guise of doing good by helping patients who need plasma-derived products. Kinda reminds me of Robin Cook's book, Coma, and the movie based on it.

In the third news item a man was judged to be unfairly dismissed but the issue is the company went after his private life to get evidence to justify firing him.
Love these words:
I look at the world and I notice it's turning
While my guitar gently weeps
With every mistake we must surely be learning
Still my guitar gently weeps 
As always, comments are most welcome.

FURTHER READING

NEWS ITEM #1
Jawarski articles
  • Early Career Research Spotlight – Peter Jaworski (Journal of the American Philosophical Association,10 May 2016)
What Jaworski doesn't mention:
NEWS ITEM #2
NEWS ITEM #3
NEWS ITEM #4

Monday, August 28, 2017

We are the world (Musings on the humanitarianism of selling body tissues)

Revised. 3 Sept. 2017 ( in 'Panda'; Further Reading)

August's blog was stimulated by three news items in TraQ's August newsletter (Further Reading):

* The Australian donor who saved over 2 million children. The donor developed anti-D from transfusions as a 14-year-old and since age 18 has voluntarily donated red cells and plasma, the later used to prepare Rh immune globulin;

* China: Liver problems boost demand for US blood plasma (China consumes half world's supply of human serum albumin);

* Canada needs blood plasma. We should pay donors to get it. Op-ed by the author of  'Markets Without Limits', the primary thesis of which is, "anything you may permissibly do for free, you may permissibly do for money.". Even selling body organs like kidneys okay and doesn't exploit the poor, if only people above a certain level of income are allowed to sell their kidneys. Indeed, it's desirable because the market in organs helps save lives. At least that's the theory.

The blog's title derives from the 1985 Lionel Ritchie - Michael Jackson song that 'United Support of Artists for Africa' (aka 'USA for Africa') recorded and became one of the biggest selling singles of all time. I wrote two earlier blogs in 2010 and 2013 using this song (Further Reading), but now I'm whistling a different tune.

EXECUTIVE VERSION: This blog will highlight my conversion to what my dear departed Dad would call crass commercialism and commodification of everything. But I've had my come-to-Jesus-moment, folks.

I've heard thought leaders like Peter Jaworski on the value of unlimited markets and the public's misconception that buying commodities such as body organs and tissues is immoral.
Peter's research at Georgetown University focuses on the moral limits of markets, including markets in blood and kidneys and the morality of markets.  He's also a Senior Fellow at the Canadian Constitution Foundation, which opposes what it sees as the watering down of constitutional principles by governments and left-wing interest groups. And now he writes opinion pieces for Canada's right-wing National Post (one of many Postmedia papers).
Henceforth, I've adopted the premise that there are no goods or services whose sale should be forbidden, except for those that it is morally wrong to sell and buy, regardless of whether filthy lucre changes hands or not. Oops! Make that shiny, clean lucre.

And your guess is as good as mine as to what 'morally wrong' may be. Because when nothing short of murder is okay to pay for - under the right circumstances - decided by gawd knows who - almost anything goes, providing it creates free enterprise markets and does some good.  

So, yes, the blog is provocative and satirical, and if I offend anyone, am politically incorrect by your standards, please forgive.

My 10 Second Pitch
I'm proposing two start-ups, Slum Dog Millionaires, Inc. and Panda Unlimited, both of which trade in human tissue for the good of mankind. Our costs are low, potential profits are high. And, best of all, there's an existing global demand for our products. 

Why continue reading? Maybe just food-for-thought on paying the poor and needy for plasma, which USA - land of 'make a buck' free enterprise - excels at? And to think about where the policy of
'anything you may permissibly do for free, you may permissibly do for money' will take the world? 

FUTURE MARKETS
Let me propose transfusion products that will do much good, create jobs and boost economies and stock markets. Forget Trump's selfish, tunnel-vision 'America first'. Many nations can play that game and trump the land of free enterprise. With my schemes, Canada - we embrace and welcome the world - will soon rule the global blood industry.

Let me expound on the business opportunities of the future in the wild-wild world of anything can be bought and sold. I plan to create two startup companies trading in body tissues.

Both start-ups are based on leveraging the populations of the world's most populous nations in 2017, which together constitute over 36% of the world's 7.5 million people:
  • China (1.389 billion ~18.47%)
  • India (1.344 billion ~17.86%) 
May even take my ideas to Canada's Dragon's Den if I can't get sufficient funding. But I'm bigly sure I can.

START-UP #1: SLUM DOG MILLIONAIRES, INC.
Slogan: 'Slum Dog Millionaires', supplying the world's plasma and making India's street urchins wealthy.

India has many street children. In 1994, UNICEF estimated that there were 11 million street children in India. Many are abducted and sold into slavery and the sex trade (Further Reading).

Slum Dog will recruit these kids into the equivalent of football (soccer in NA) academies. Fatten them up, get them healthy, send them to schools, indoctrinate them to believe they can save so many patients. Patients who  need plasma derivatives like intravenous immune globulin (IVIG), whose potential uses grow exponentially (even if many are based on artificially created uses), and human serum albumin, whose use continues to grow in China (Further Reading).

Though Slum Dog's profits will be in the $millions, perhaps $billions on the world's plasma derivative market, we'll give the urchins a few rupees, far more than they've ever seen before. We're generous that way, it's in our DNA. Why? Because
  • Maximize profits, decrease costs, is what free enterprise is all about, folks. 
Our strategy is to increase market share. Moreover, we're going to channel what Saudi Arabia has done with over production and flooding the market with oil, driving the cost down. If successful, we will cause the price of paid plasma and its derivatives to drop precipitously. The other big players in the plasma fractionation market will let staff go, struggle to survive. Profits will no longer justify investments:
  • CSL Ltd. (Australia) / Grifols S.A (Spain) / Baxalta Incorporated (U.S.) / Octapharma AG (Switzerland) / Kedrion S.p.A (Italy)
SECOND BUSINESS LINE
Wait, there's more.... It's not just the kids' plasma. Slum Dog has another business line. We can leverage the street urchins' red blood cells to generate profits for investors. Because in free enterprise, profits are all that count.

The urchins' young blood is a potential source of the elixir of youth. We're negotiating with USA's Ambrosia (Further Reading) as we speak. And we have the advantage of India already being a medical tourist destination (Further Reading), hence can decrease our advertising costs. Buyers come to us. Sweet, eh?

BOTTOM LINE
OMG, the good 'Slum Dog Millionaires' does. Following basic business practice, we'll  minimize expenses to street urchins, maximize our own profits, likely in the $billions, just as the world's paid plasma industry does.

That we get rich on the backs of the poor, children to boot, (risking their health) is only fair because we risk much by funding donation centers and equipment. Street urchins only donate their body tissues (red cells and plasma), which is no big deal, right? And it's all moral because some good comes of it.

STARTUP #2. PANDA UNLIMITED
Just to show you I'm not a total markets-not morals-rule creep, Slum Dog has another business line, in its subsidiary, Panda Unlimited.
Slogan:'Panda Unlimited', supplying the world with life-saving Group O Rh-negative red blood cells

'Panda blood' refers to the Rh-negative blood type in China, which, as the phrase suggests, is 'as rare as pandas.' (Further Reading).

Only three out of 1,000 people in China are Rh-negative. But the frequency of Group O in China is 47.7%. If multiplied by the total 1.389 billion population, the number is almost 2 million people, of which ~72% are between 15 and 64. So, potentially nearly 1.4 million blood donors. And increasingly Chinese are learning English, which helps, as you will see below.

Panda Unlimited's vision is to supply the entire world with Group O Rh-negative RBC.

Our ongoing capital and operational costs will include buying consumables like needles, tubing, blood bags, refrigeration storage, collection sites and their overhead, transportation, blood testing instruments and reagents. But because of massive volume, we expect to drive suppliers' prices down.

About transportation, we have an awesome supply chain management system, whose key component is drones (Further Reading). 

We've partnered with Amazon, one of the richest companies in the world, whose Prime Air will use drones to deliver goods, albeit it's not ready for prime time yet. (Further Reading)

As for collection centre costs, we've talked to Beijing about using Tiananmen Square once per week as weather allows, with royalty payment of 1% of our annual profits. As the world's largest square Tiananmen can hold up to a million people. With collection set-up and donation chairs, it still offers capacity of at least 100,000. In colder weather we plan to use heated giant tents.

Staffing costs, normally substantive, will be minimal. Forget cost efficiencies gained by RNs supervising inexpensive donor care associates for blood collection. We're  joined with Japan and Hong Kong's humanoid robotics makers (Further Reading) to pilot a robotics system for blood collection. These robots never tire, will work 24 hr shifts, don't demand raises and forget the burden of perks like health insurance, sick leave, and pension plans.

Face it, the more people you can eliminate in your operation, the more profits you make.

How will we entice the one million+ Group O Rh-negative Chinese to donate voluntarily? We've taken a page from US blood centres and offered various goodies. Moreover, even China has tried incentives (Further Reading):
  • Children of Chinese blood donors offered grades boost as incentive
Our biggie? We'll sweeten the pot by promising Chinese male Group O Rh-negative donors that they will be entered in a lottery to win an Rh-negative wife from Canada or the USA.

Because China's one-child policy left its men with a severe shortage of women to marry, they should leap at the chance. For example, There's now a black market selling women’s eggs to infertile couples who can now try for up to two children after the scrapping of the one-child policy.
  • Schoolgirl’s brush with death from selling her eggs casts spotlight on China’s black market
Added plus is that after 12 RBC donations (2 years) per male donor, they, their Rh-negative wives and offspring, can enter a lottery to migrate to Canada with transportation and legal costs paid courtesy of Panda Unlimited. We'll fund one lottery/month, meaning we potentially lose 12 donors per year. Unless no one's lottery ticket is drawn.

The only proviso is, if they meet Canadian blood donor criteria, they must agree to donate to one of Canada's government-funded blood suppliers for one year (six times). That way, Panda Unlimited gains credit as a supporter of CBS and H-Q and is not seen a competitor.

How will Panda motivate Group O Rh-negative women in Canada and USA to marry men in China?

1. We'll appeal to unmarried folks by advertising on all the Internet dating services, especially to women worried about their biological clocks ticking down and with iffy marital prospects, who desperately want children;

2. We'll pay their costs to travel to China to meet prospective mates F2F if required, or they can talk via the Internet. It's up to them which men they choose;

3. For every Rh-negative child produced they'll get a bonus payment via a prepaid credit card (as is done with paid plasma in USA and now Canada);

4. We'll support their efforts to bring spouse and children to Canada, which welcomes immigrants.

SECOND BUSINESS LINE
Wait, there's more....Our other business line is harvesting the recovered plasma from whole blood donations and supplying it to our parent company, Slum Dog Millionaires. No additional costs except transportation and storage, with mega-profits. Pretty sweet, eh?

BOTTOM LINE - OMG, the good Panda Unlimited does:
  • China's men have wives and offspring to care for them in old age; 
  • Moreover they can move to the West, experience democracy for first time in their lives;
  • Unmarred Western women can dream of children to fulfill their maternal instincts;
  • Panda stimulates economy and lessens the impact of baby boomers retiring; 
  • Supplies the world with Group O Rh negative RBC.
Yes, we're making mega-bucks off our blood donors who desperately want to mate and have families. But it's win-win-win-win. Panda wins - blood donors win - childless women win - world wins. Winning/doing good justifies everything. Even selling body corpses for profit, which may be Slum Dog Millionaires third business line

FOR FUN
'We are the World' is perfect for this blog. We and our bodies are commodities to be traded for profits that benefit free enterprise companies, their owners, and investors. Markets that value profits over exploiting humans rule. Of course, I'm kidding. Please Resist!

We are the world
We are the children
We are the ones who make a brighter day
So let's start giving...


How many iconic US artists can you recognize? And, admit it. This production and these singers are awesome, a word I seldom use.
  • We are the world (1985, written by Lionel Ritchie and Michael Jackson for 'USA for Africa' benefit)
As always, comments are most welcome.

FURTHER READING
Earlier blogs
  • We are the world - Musings on how we can lessen the global trade in body parts (15 Feb 2010)
  • We are the world - More musings on commercialization of the blood supply (13 April, 2013)
TraQ newsletter items
Slum Dog resources
Panda Unlimited resources

Saturday, July 22, 2017

Both sides now (Musings on where careers take us)

Updated: 2 August 2017

July's blog originated when, after decades of hoarding 'stuff', I finally decided to clean out a file cabinet. In the Medical Laboratory Science (MLS) folder, where I'd taught for 22 years+, I came across a graduation talk I'd given in 1991. The talk got me thinking about preserving (via a blog) some of the history of med lab techs who got caught in the cost constraints of the 1990s and had to work outside Canada. Some eventually decided to transition to other careers. 

The idea for the blog further crystallized when a local radio station used as its 'talking point of the day' 
  • 'How did your education (or lack thereof) play into your career? Are you doing the job you trained for and can people still learn on the job?'
I thought the question's focus was slightly off because it assumed that education for a career was mainly for a particular profession's job-specific tasks and ignored all the transferable skills students learn with a good professional education.

Executive version: What follows is an edited version of the grad talk followed by my musings on what happened to the careers of some graduates in the 1991 class. My thesis is that, if education for a career is sound, graduates come out with the self-confidence and transferable skills to transition to wherever life takes them.

Why read it? The educational issues discussed relate to med lab techs/biomedical scientists everywhere and cover a few of the transferable skills essential to any health professional. As well, the blog may resonate with nurses and physicians who find themselves forced to travel to foreign lands for job opportunities. 

Today where I reside (Edmonton, Alberta, Canada), depending on which provincial political party wins the election in 2019, health professionals could find themselves back in the 1990s when medical laboratory technologist, nursing, and laboratory physician jobs all but dried dried up due to the government's obsession with balanced budgets. 

The blog's title derives from an iconic 1967 song written by Canada's Joni Mitchell. I used it once before for a 2013 blog.

GRADUATION TALK TO MLS CLASS of 1991
What follows is an edited version of the talk. It's a run-of-the-mill talk but makes a few points I think are key to a sound education and still apply 26 years later.
Thanks very much Terry for your generous introduction. I am glad to have this opportunity because there are a few things I still need to cover with this class. First, I thought we would have a spot quiz, because students love them. Be aware that some of the answers will only make sense to the graduates. Let’s begin, starting with a test of your long-term memory.
Q #1: How many 1st-year MLS students does it take to change a light bulb?
  • Five. One to change it and four to set up Kohler illumination.
Q #2: How many 2nd-year students does it take to change a light bulb?
  • None. At least not in my class. You see, they were all asleep during my Powerpoint presentations and the light would only have disturbed them.
Q #3: How many 3rd-year students does it take to change a light bulb? [3rd yr is the clinical rotation yr]
  • The whole class. One student to change it and the rest to complain that their friends in other faculties had all summer off to do it.
Q #4: This one is a test of your short term memory. How many 4th-year students does it take to change a light bulb?
  • Again, the whole class. One to change it and the rest to complain that it should be deleted from Path 401 [a catch-all course, long since dropped].
Q #5: How many MLS instructors does it take to change a light bulb?
  • Ten. One to change it and nine to evaluate whether it was done right.
Now that the spot quiz is over there are a few things that I would like to talk to you about in a more serious vein. 
A few weeks ago I went to the Ambassador Awards at the Convention Centre. It was attended by people from all walks of life who belonged to associations like the CSLT [now CSMLS] that can bring conventions to the city. The organizers gave out awards and asked all of us to act as ambassadors by promoting Edmonton as a convention site. 
The thought occurred to me that in one way or another we all act as ambassadors. For example, when we are tourists in a foreign country, or when we interact with visitors to our city. 
So I would like to talk tonight about the idea that all of you—the MLS graduates of 1991—are going to be ambassadors for MLS whether you realize it or not. No matter what the future holds for each of you, all of the people you will meet will be gaining impressions of MLS through you, your actions, and attitudes. 
Now before you say, “Good grief! I can’t handle the pressure—-MLSers for life”—I want to tell you that I have great faith in each and every one of you. As an MLS instructor I have been privileged to share a part of your life for the past few years. 
Let me explain why I think that you will be great ambassadors. In a way, I feel like the mosquito in a nudist colony. I don't know where to begin.  
First, there are all of the things you have learned while in MLS. And I’m not talking about the knowledge and technical skills you have assimilated, although these are important. You have learned so much that what you have forgotten would fill a library.No—I’m talking about transferable skills that you will find useful all your lives. 
For example, you have learned how to be good listeners. Goodness knows you have had enough practice being listeners during your time here. As you begin your careers, remember the words of a wise person who once said, “good listeners are not only popular everywhere, but after a while they know something.” I have learned much from listening to you over the years.
You have also learned how to communicate clearly, both orally and in writing. Who can ever forget their first teaching assignment? I should explain that our students give at least three oral presentations to classmates and instructors beginning with teaching assignments during 3rd year. 
I’m sure that some of you think that teaching assignments were cruel and unusual punishment—both for the student and the audience. But, boy, do they ever pay off. The progress you made was really shown when you presented your 4th-year research projects. Your instructors and supervisors were impressed. 
This ability for you to make presentations will be a real plus for you in any career. I tell you this because I have listened to many technologists, scientists, and doctors who have not had the advantage that teaching assignments provide—namely to express ideas clearly and concisely. And listening was brutal.
There are many other intellectual skills you have learned. For example:
  • Your grasp of the scientific method and all that entails; 
  • The ability to be skeptical about so-called established knowledge, and yet to be open-minded about complex issues;
  • You know that it is okay to say, “Gee, I  don’t know, but I will find out”;
  • Most important of all, you know how to learn
You will draw on these skills over and over again— especially because medical laboratory science is evolving so rapidly. 
I would like to shift for awhile to some of the ways you have all grown in your personal development. 
Those of you who entered MLS lacking self-confidence have seen your belief in your abilities increase. Self-confidence is essential because no one will believe in you if you don’t believe in yourself. I’m not talking about being over-confident and self-important, but rather about the quiet self-assurance of people who are competent and know it. 
Conversely, if you came with a fair degree of self-confidence—if you were like me at 18 (and trust me, I was 18 once—and thought I pretty much knew everything) —then your experiences in MLS have added to your growth by teaching you humility. 
Your entire 3rd year was an exercise in discovering your strengths and weaknesses, coming to terms with them, and accepting both praise and criticism gracefully. 
It was hard to be evaluated each and every day of your hospital rotation; it was hard to accept feedback that you may or may not have felt was justified. But you all did it, and because of this you will have a big advantage in the workplace, as well as in life.  
Having a positive approach to learning will always serve you well. You know that imperfection is only human. The important thing is that we all try to do better. And keep in mind that misery is optional. 
You have also learned what friendship means. In the years ahead, you will remember your friends very fondly . One definition of a friend is “a friend is one who dislikes the same people that you dislike.” There is a lot of truth in this, but a better way to think of friendship is to realize that the only way to have a friend is to be one. You have all done that during your university days. 
Let me remind you that universities have always stood for the dignity of each human being—for the belief that each individual is to be appreciated for what they uniquely think, do, and feel. I want you to realize that you are important and have had an impact on your friends and teachers in MLS. 
Earlier I said that, whether you realize it or not, you are going to be unofficial ambassadors for MLS. Over the years, you have seen many role models—instructors, professors, nurses, doctors, and technologists. As ambassadors-—-with personalities and styles of their own—they succeeded to varying degrees in creating good-will for their professions. Soon you too will have this responsibility. 
As you leave MLS, remember the people who have influenced you. Think of those who have treated you with dignity and patience, who smiled rather than frowned, who took the time to criticize constructively, who showed you how to solve problems as medical laboratory scientists, who loved their subject, and who challenged you to be your very best. 
These are the people you will want to emulate as you become role models for others. And now, graduates—this is your night. You have struggled and succeeded in a difficult program. We, your instructors, are very proud of you. You have chosen a rewarding and challenging career.  
In conclusion, it's a cliche but always believe in yourself. You are graduates of the most rigorous Medical Laboratory Science program in Canada and one of the best in the world.  And don't be afraid to dream of what you want in life. No matter what the future holds, you have the right stuff to succeed.
MUSINGS
Of the 22 students in the 1991 MLS graduating class, here's what I know 26 years later about their careers. Most, as would be expected, went on to have careers as medical lab technologists/scientists. But the 1990s brought severe healthcare cuts in Alberta and throughout Canada and jobs became scarce. Graduates' careers I'm aware of:
  • Went to NZ to work for New Zealand Blood Service (NZBS) - 2
  • Worked for CBS, Canada's national blood supplier for years - 2
  • Dentist - 1 
  • Lawyer - 1 (after years of working as a med lab tech in Canada and later for NZBS)
  • PhD (microbiology) - 1
  • Gynecologist -1 (who was in Christchurch, NZ on a fellowship learning advanced laparoscopic surgery when the earthquake struck in 2011)
  • Radiologist - 1 (after many years of working as a med lab tech in USA)
To me, this validates that graduates of MLS at the University of Alberta learned many transferable skills and had the self-confidence to believe in themselves and accept challenges, as well as to dream. As one example, the MLS grads who went to NZ to work for NZBS (six in all from several graduating classes) were brave indeed and went through all the government hoops and regulations, requiring incredible stamina and belief that they could do it, no matter what. 

ANECDOTE #1
I'll share correspondence I had with one grad (John) 8 years later (when he was 30 years old) and again, 14 years post-graduation. John, like most MLS grads, had written the USA's ASCP(MT) exams when he graduated from the University of Alberta MLS program. As a result, he could go to the USA under NAFTA with a BSc (MLS) and work in a profession that was deemed needed in the United States. He worked for years as a med lab tech in Montana and also acquired EMS certification and worked part time as a firefighter. 

He wrote me and 3 others in MLS in 1999 because he had obtained his green card and could apply to U.S. medical schools and needed references from his instructors.

Bottom line was that John was accepted into an American medical school in ND, interned in Spokane, Washington, and later got a residency at the coveted Mayo Clinic in 2005, followed by specializing in radiology.He also did a fellowship in Neuroradiology at the Mayo Clinic. 
Mayo Clinic info (1999):"The Mayo residency and fellowship programs are among the most sought-after in the world. Last year, nearly 7,000 people applied for slightly more than 360 positions....Last year, the medical school accepted only 42 new students and only about 5% of those who applied for a residency or a fellowship."
Going back to MLS, in the 3rd year, students rotate through the clinical laboratories in groups of 3 or 4. I distinctly recall John's group because they were so motivated and, more importantly, so much fun to teach. Honestly, everyone should be so lucky to have such students.

John rotated with two female students (Donna and Jennifer), who both went to to work for NZBS in Hamilton, NZ for several years. Jennifer eventually became a lawyer and now works for a law firm in Edmonton where she represents hospitals/health regions and their employees, including AHS . Donna, who prior to NZ had worked for years in a Las Vegas mega-lab where technologists were more like factory workers, later worked for CBS and now works in a local hospital laboratory.

My spouse and I visited NZ for 6 weeks in 1998-99 over Christmas/New Years and touched base with two of the MLS grads, including Donna, who had the courage to go to a foreign country to practice their profession. They had made the best of a bad situation and were loving their foreign adventure.

These grads believed in themselves and were great ambassadors for MLS at the University of Alberta.

ANECDOTE #2
While the MLS grads worked for NZBS, a US software company visited to demonstrate and pitch its blood bank software. Reason I know this is that the software company (Wyndgate Technologies, now Haemonetics Software Solutions) contacted me. 

Specifically, they wanted to know if MLS had more grads like the ones working at NZBS because they were very impressed with them and would love to hire some.

Bottom line: Two MLS grads were brave enough to transition to software testing and moved to Sacramento, California to work for Wyndgate in 2000. One worked for Wyndgate/Haemonetics for 15 years, latterly in a senior management position.

FOR FUN
I chose Joni Mitchell's 1967 song for two reasons. Of note, it has been covered ~600 times by other artists and counting. 

First, I love it. By any standard, Canada's Joni Mitchell is a songwriting genius.

Second, to me it means that life isn't always what you expect it to be. We win some, lose some in the careers we choose but in the end we're left with the illusion of what we hoped it would be. And that's okay providing we acquired the skills to follow our dreams past the illusion. Perhaps too philosophical?
I've looked at life from both sides now 
From win and lose and still somehow 
It's life's illusions I recall 
I really don't know life at all. 

As always, comments are most welcome.

Wednesday, June 28, 2017

Revolution (Musings on how e-mail destroys work lives)

Updated: 4 July 2017
June 29, 2007, Steve Jobs introduced a revolutionary gadget 

June's blog had a long gestation. Perhaps it's a baby elephant as it's been in the womb for more than a year and a half.  Why so long? Likely because I've hesitated to 'give birth to a child' who may be unwelcome. But I'm hoping readers can accept the latest baby-blog in the spirit in which it was created.

BACKGROUND
Bear with me as I explain the experiences that caused me to write the blog before getting to the nitty-gritty content.

In brief, I've been a user of personal computers from the get-go. My first PC was the PC Jr using command-driven MS-DOS software (Aargh!). 


Also was an early adopter of the Internet when it came to Canada, mainly because of the exciting potential to communicate with colleagues around the globe. In those prehistoric times terms like archie, ftp, html, telnet, usenet groups, and veronica ruled. Indeed, to create my first website, I learned how to code html from a textbook. Then...DRUM ROLL....
  • 1984: Steve Jobs introduced the first Macintosh with GASP! a graphical user interface (GUI) and mouse;
  • 1986: Eric Thomas invented listserv software for mailing lists and commercialized it as LSOFT in 1994;
  • 1989: Tim Berners-Lee invented the World Wide Web;
  • 1995: Bill Gates' Microsoft introduced its GUI OS, Windows 95. 
And, all of a sudden, the Internet was off and rolling, Bigly (as US President Trump might say). A revolution in communication whose evolution is far from over. 

Pricing tidbits: After using computers run on MS DOS, I became a 'Macaholic' for years, although Macs were truly expensive in the early years. For example, in 1988 bought a Mac SE with basic software for $5595, 4 MB memory upgrade in 1990 for $660, and 40 MB hard drive in 1989 for $1300. In 1991 got a MaC LC with basic software for a whopping $8111, on a line of credit. Yikes! 

Of course, once Windows 95 appeared due to consulting contracts, I ultimately was forced back to the MS dark side.

Over decades of observing how folks communicate on the Internet including running mailing lists for med lab professionals, writing blogs, and corresponding with colleagues around the globe, I'd like to say a few things about e-mail. The blog is not strictly a transfusion-related blog, but I hope transfusion professionals everywhere will be able to relate to its musings on communication.

Executive version: The blog's content offers tidbits for how to communicate more effectively via e-mail, but I'm under no illusion that readers will take them to heart. Perhaps agree in principle to the ideas but, without executing them, ideas are worth nothing. And old habits are hard to break.

The blog may (or may not) be the first in a series of tips involving other communication such as presentations and scientific writing. I'll play it by ear.

Much has been written on e-mail and many valuable resources exist. Hence, I do not intend to re-invent the wheel or to be all inclusive. What follows are just a few musings on things that bug me most.

The blog's title comes from a 1968 Beatles ditty.

IS E-MAIL THE BEST CHOICE OR EVEN NECESSARY?
Most professionals with job-related e-mail accounts know that it's over-used and abused and a major consumer of valuable work time. Indeed, much e-mail is a total waste of time (Further Reading).

Seems obvious, but for each message sent, do you first decide whether e-mail is the most effective way to communicate whatever it is you want to communicate. Before sending a message or responding to one, do you ask if it's truly necessary and the best way to achieve its purpose? Likely not. Today e-mail is an automatic response to communicating.

Yes, e-mail is the easiest way to communicate but may be a poor, even horrid, way for a given objective. Plus e-mail has the dreadful disadvantage of being easy to misinterpret. For one thing we cannot see the sender's facial expression, the smile and twinkle in the eyes. Words said even warmly can come across as blunt and harsh.

FACT: E-mail has run wild with little to no purpose for a long time So many e-mails about so little clog staff in-boxes and take away precious time from the real work of providing patient care, ensuring safe transfusion.

Bet you all know a TM professional (lab technologist, nurse, or physician) whose in-box bulges with 100s of e-mails read once but not yet dealt with. Or on return from vacation, even more in-box clutter? 


Abuse like that forces staff to read work e-mail when on holidays, destroying the entire aim of getting away from work pressure.  Executives and managers abuse staff this way and get away with it. Ultimately the buck stops with employers who do nothing to stop the practice and may even encourage it.

And you know what? I bet that, if the 100s of e-mails were never read, the universe would still unfold as it should.

TIDBITS: HOW TO WRITE E-MAILS
In this section I concentrate on a few things that bug me most about writing e-mail messages. From experience, I believe that many lab professionals, regardless of age (including those who have known e-mail, social media, the Internet all their lives) do not know how to write and respond to e-mails effectively.

1. ABOVE THE FOLD
Why keep the purpose of an e-mail message a secret, as so many do? For most job-related e-mail and correspondence with colleagues, it's critical to convey the purpose and any action required 'above the fold' (newspaper parlance).

Nothing is worse than wading through an e-mail to find the key bit at the end. It's abusive of the reader's time and reminds me of the typical telemarketing call:

  • You answer, hear nothing but background noise. 
  • After a few seconds that seem an eternity, someone asks you something like, 'How are you today?' 
  • My response, sometimes said aloud, is 'What the hell do you want? I'm busy.' 
  • Or what a pal typically says forcefully but more politely: 'What do you want?'
Learning point: When writing e-mails, specify the purpose and say what you want recipients to do up front, above the fold. Don't keep it a frigging SECRET.

FACT: Today most professionals are so overwhelmed with  e-mail that they typically scan messages with almost none of it being processed in their brains. This makes it critical to get their attention immediately. Also, using all-caps headings can help to focus the mind.

Examples of what to write above the fold include

  • No response required, for information only. Read now (it's time-sensitive) and file;
  • Your immediate response  to a question is required below. Please do NOT 'reply to all';
  • Please confirm receipt. It's FYI only but important enough that I need to know that you received the message. Replying 'Got it' suffices. 
2. SUBJECT LINES
Vague Subject Lines that tell the receiver next to nil about the e-mail's content are another gripe.

First, to have any value, Subject Lines of messages to individuals and to mailing lists must be precise and descriptive. As a long time manager of mailing lists, most subscribers have learned to draft useful Subject lines. But I'm always surprised that some continue to use Subject Lines such as 'Question'. Not very informative to readers and makes list archives useless if not revised by the list moderator.

Second, with a series of e-mails on the same topic between even two persons, keeping the original Subject Line for multiple messages in a conversation is not helpful. Multiple messages with identical Subject lines don't give a clue as to which ones contain the specific info people may want to refer to later.

Learning point: Make Subject Lines as useful as possible to the receiver. Think about the TV shows you want to view. Would Sports Contest, Police Drama, or Reality TV be useful listings on your cable TV guide?

3. SHORT PARAGRAPHS
Short paragraphs in e-mails are as important as they are on web pages or in any writing (annual reports, even novels).

But to write in paragraphs, you need to know what they are. Are such basics even taught anymore in the age of texting? (Further Reading)

Learning point: With e-mails I recommend that writers break information into short paragraphs even if they deal with an over-arching theme, but have a discernible sub-topic. When reading long paragraphs, eyes invariably glaze over.

4.  PRIVACY
Some colleagues. and administrative assistants in university faculties and hospitals include everyone in the visible Cc field as opposed to the blind carbon copy (Bcc) field.

An easy alternative is to use your address (sender's address) in the To: field and put recipients in the Bcc field. That way privacy is protected, including if any recipient decides to forward the message to others beyond the intended recipients.

Added benefits of the Bcc field: 

  • If someone goofs and replies by hitting 'reply to all', the message will not go to those in the Bcc field; 
  • It's an anti-spam device. Should someone's computer be infected with a virus that harvests e-mail addresses, addresses in the Bcc field are protected. 
Learning points: Many people do not want their e-mail address to be distributed to people they do not know. And what folks write to you is for your eyes only. How else can they be honest?

5. HANDLING INFO OVERLOAD
Most experts say to limit reading e-mails to set times of the day, perhaps once in the morning and once in the afternoon. But I know of few who have the insight and guts to do it. There's always the fear that you may miss something, a silly fear because most e-mail is an unimportant waste of time.

Research shows that when you interrupt your work with a distraction such as e-mail, it takes much time to recover and re-focus on important tasks at hand. Yet folks do it constantly throughout the work day. E-mail gobbles up so much staff time it borders on the criminal, meaning it does real harm to an organization's productivity.

Learning point: Why not try being the boss of e-mail versus being its poodle? Breaking free not only involves reading e-mail perhaps twice a day but also dealing with messages at the time of first reading. Reading messages and keeping them so that you need to read them again at a later date is an insane waste of time.

It's similar to quitting smoking. You're the boss - you can choose NOT to smoke. I made the choice 30 years ago after being a nicotine-addicted chain smoker. You can choose to be the boss of your e-mail. It's within your power, albeit not easy. New life-changing habits take much effort.
6. ETIQUETTE
Tips on e-mail and mailing list etiquette are all over the Internet. Many years ago I wrote guidelines for MEDLAB-L (Further Reading). For this blog I'll only offer a few tidbits:

 1) As a general rule do not share personal e-mails without the sender's permission. While it's true that once anyone sends an e-mail, they never know where it will end up, But respect the sender's privacy as you would want yours to be respected. Do not share without permission, unless there's a compelling reason to do so, such as you think you are being abused and need to discuss it with others.

2) Never send an e-mail in anger or with a flippant response and especially not after midnight. Give it a day or two to reflect upon.

3) When you e-mail a colleague for help or advice on any topic, once they reply, have the courtesy to say thanks. That way they know you received the reply and, more importantly, appreciated them taking the time and effort to help. I can't count the times I've spent hours assisting folks with a request (some I know but many who are strangers) to never hear from them again. Some experts say to axe the thanks (just more in box clutter) but to me it's common human courtesy and let's folks know you got the reply.

4) Because e-mail is such an impersonal medium and open to misinterpretation, take the time to personalize messages as if you were talking to the recipient in person. Again, some experts recommend cutting the niceties because they're superfluous time wasters. But to me, the personal touch is essential.

5) Keep e-mails short and, as noted earlier, consider using headers to focus the recipient's attention. Involves editing original for brevity (as you would with Twitter's 140 characters), but more importantly, deciding what is fluff that adds nil to the e-mail's key message.

However, do not sacrifice the personal touch for brevity. Connect with colleagues and encourage them to see you as a real person with shared experiences they can relate to.

6) Proofread e-mails as you would scientific papers submitted for publication. E-mail messages reflect on you.

Learning point: See e-mail as a communication medium with an etiquette similar to talking face-to-face. The key point is to respect colleagues as you would want them to respect you.

FOR FUN
The Internet is a revolution that changed everything, which is why I chose Revolution for the blog's title. So many good outcomes and some not so good. On balance, to me life before e-mail was better than life after. Why? Because today time for professionals to reflect is limited. Yep, we can communicate worldwide but at what cost?

Professionals are now slaves to mostly useless e-mail. With multi-tasking 24 hrs a day, no one has time to reflect. It's hours of mindless skimming of e-mail messages that did not exist before. Non-productive, non-efficient wasted time at workplaces, abuses staff time at home and on holidays, and contributes nil to patient safety. 


As always, comments are most welcome whether you disagree with me or would like to add more pet e-mail peeves. You can do so anonymously, and include your name or not. 


FURTHER READING

Tim Berners-Lee - Inventor of WWW

Eric Thomas - Inventor of Listserv

On paragraphs

Is text messaging infecting or liberating the English language? Judge for yourself, as we rewrite classic texts in txt. (BBC, 2003)

MEDLAB-L Guidelines 


The iPhone turns 10 (Just a kid and who knows what it will be when it grows up or if it becomes landfill like so much technology)